Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill.

Yingying Tian; Beibei MA; Shangyue YU; Yilin LI; Hailuan Pei; Shiqiu Tian; Xinyue Zhao; Chuang Liu; Zeping Zuo; Zhibin Wang

Return

Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill.

Author: Yingying TIAN ¹ ; Beibei MA ² ; Shangyue YU ¹ ; Yilin LI ¹ ; Hailuan PEI ¹ ; Shiqiu TIAN ¹ ; Xinyue ZHAO ¹ ; Chuang LIU ¹ ; Zeping ZUO ² ; Zhibin WANG ¹
Author Information

1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
2. Research Institute of Beijing Tongrentang Co., Ltd., Beijing 100079, China.
Publication Type:Review
Keywords: Dahuang Zhechong Pill; anti-tumor effect; pharmacological mechanism; traditional Chinese medicine
From: Chinese Herbal Medicines 2023;15(2):169-180
CountryChina
Language:English
Abstract: Cancer still has elevated morbidity and mortality, which undoubtedly impacts the life quality of affected individuals. Remarkable advances have been made in cancer therapy, although the toxicities of traditional therapies remain an obvious challenge. Dahuang Zhechong Pill (DHZCP), developed by Zhongjing Zhang in the Synopsis of the Golden Chamber, represents an effective anticancer traditional Chinese medicine (TCM). In this review, it was found that DHZCP is therapeutically utilized in liver, lung, gastric, pancreatic and other cancers in clinic. Pharmacological evidence showed that its anti-tumor mechanisms mainly involve induced cell cycle arrest, apoptosis and autophagy, as well as suppressed tumor cell proliferation, obstructed angiogenesis and metastasis, enhanced immunity, and reversal of multidrug resistance. The present review provides a solid basis for the clinical application of DHZCP and may promote the wide use of TCM in clinical antitumor application.